Buchanan, R. W., Barch, D., Csernansky, J., Goff, D., Gold, J., Jarskog, F., … Marder, S. (2010). MK-0777 FOR THE TREATMENT OF COGNITIVE IMPAIRMENTS IN PEOPLE WITH SCHIZOPHRENIA. In Schizophrenia Research (Vol. 117, pp. 119–119). Elsevier BV. https://doi.org/10.1016/j.schres.2010.02.053

Buchanan, Robert W., Deanna Barch, John Csernansky, Donald Goff, James Gold, Frederick Jarskog, Daniel Javitt, et al. “MK-0777 FOR THE TREATMENT OF COGNITIVE IMPAIRMENTS IN PEOPLE WITH SCHIZOPHRENIA.” In Schizophrenia Research, 117:119–119. Elsevier BV, 2010. https://doi.org/10.1016/j.schres.2010.02.053.

Buchanan RW, Barch D, Csernansky J, Goff D, Gold J, Jarskog F, et al. MK-0777 FOR THE TREATMENT OF COGNITIVE IMPAIRMENTS IN PEOPLE WITH SCHIZOPHRENIA. In: Schizophrenia Research. Elsevier BV; 2010. p. 119–119.

Buchanan, Robert W., et al. “MK-0777 FOR THE TREATMENT OF COGNITIVE IMPAIRMENTS IN PEOPLE WITH SCHIZOPHRENIA.” Schizophrenia Research, vol. 117, no. 2–3, Elsevier BV, 2010, pp. 119–119. Crossref, doi:10.1016/j.schres.2010.02.053.

Buchanan RW, Barch D, Csernansky J, Goff D, Gold J, Jarskog F, Javitt D, Keefe R, Lieberman J, McEvoy J, McMahon R, Marder S. MK-0777 FOR THE TREATMENT OF COGNITIVE IMPAIRMENTS IN PEOPLE WITH SCHIZOPHRENIA. Schizophrenia Research. Elsevier BV; 2010. p. 119–119.